GENE ONLINE|News &
The Rejuvenated Promise of RNA Therapeutics
The field of RNA therapeutics is a budding one as compared to small molecules or protein therapeutics. Its recent surge must be attributed to the decades of work put into eliminating various drawbacks. “With a number of drugs in late-stage trials, the field is going to take off” says Dr. Judy Lieberman, Professor, Department of Pediatrics, Harvard Medical School. Since 2006, she also serves as an elected member of the Scientific Advisory Board for Alnylam Pharmaceuticals.
It's free! Log in now to read
LATEST
Definium’s Psychedelic Anxiety Drug DT120 Moves Closer to the Mainstream With a Phase 3 Win
2026-08-14
JAMA Network Open Study Links Agent Orange and Burn Pit Exposure to Veteran Health Outcomes
2026-08-14
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia
